The Food and Drug Administration has approved new Nucynta for the adults suffering from chronic pains, Johnson & Johnson notified Friday.

The painkiller is an extended-release edition, and can be taken twice a day by adults suffering low to high density of enduring pain.

A number of large, important drug companies have announced major cuts to the cost of the vaccines that they provide to people in the developing world. GlaxoSmithKline (GSK), Johnson & Johnson, Merck and Sanofi-Aventis have all said that they will cut prices for Gavi, an international vaccine alliance.

The results of phase III trial of drug abiraterone acetate have revealed that it extends on an average four months of life among men with prostate cancer. The drug is manufactured by Johnson & Johnson unit Centocor Ortho Biotech and is marketed as Zytiga.

Zytiga (abiraterone acetate), a drug manufactured by a major healthcare company Johnson & Johnson for treatment of metastatic prostate cancer among men, has been approved by the US Food and Drug Administration.

The health care company, Johnson & Johnson has announced to acquire the Swiss medical-device manufacturer, Synthes Inc. The deal is said to be worth $21.3 billion. Discussions with Synthes are going on regarding a potential deal.

Drug manufacturing giant firm, Johnson and Johnson has said that it is going to call off as many as 57,000 bottles of Topomax. This announcement has been made after there was a complaint made by consumers that this drug has some uncharacteristic odor. Topomax is a prescribed drug and it is the treatment for seizures.

The Johnson & Johnson has been grappling with charges of paying kickbacks to high officials to give positive signals to their projects.

Johnson and Johnson is a big name in the field of Healthcare. They are now here with revamp issue of their Consumer care unit. This has been done for the aid of those people who have complaints against their products. It has been done in order to improve the reputation of the firm.

Customers had made complaints about making compromises with the sterile barrier on packaging and this has led to Johnson & Johnson's Ethicon unit recalling about 360,000 units of products used to drain surgical wounds.

The Center for Medicare and Medicaid Services has forwarded a proposal in which it has recommended not to change its coverage of anemia drugs made by Amgen Inc. (AMGN) and Johnson & Johnson (JNJ).